Karolinska Development
1,02
SEK
+0,79 %
Mindre end 1K følgere
KDEV
NASDAQ Stockholm
Investment
Financials
Overview
Ownership
Investor consensus
+0,79%
+15,38%
-1,92%
+7,03%
+2%
-38,18%
-59,84%
-60,69%
-97,12%
Karolinska Development is an investment company focused on long-term equity investments in biotechnology and pharmaceutical companies. The company's goal is to develop promising medical innovations stemming from academic research at Karolinska Institutet and other universities in the Nordic region. The company's portfolio includes companies in sectors such as biotechnology and medical technology. Karolinska Development was founded in 2003 and is headquartered in Solna, Sweden.
Læs mereMarkedsværdi
275,48 mio. SEK
Aktieomsætning
159,65 t SEK
Omsætning
1,84 mio.
EBIT %
-497,83 %
P/E
-
Udbytteafkast, %
-
Finanskalender
29.8
2025
Delårsrapport Q2'25
14.11
2025
Delårsrapport Q3'25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Karolinska Development’s portfolio company OssDsign has treated 10,000 patients with OssDsign Catalyst in the US
Karolinska Development’s portfolio company Umecrine Cognition presents data validating novel clinical scale in PBC at EASL 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools